Social Services Grants
75 open opportunities. Open federal grants for income security and social-services programs, each explained in plain English with eligibility, deadline, and award amount.
BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional)
Due Jun 15, 2027National Institutes of Health · Amount varies
This NIH BRAIN Initiative (U01) program funds development of next-generation sensors and bioelectronic devices that synchronize with brain recordings to build computational models of human and animal behavior. Eligible applicants are research organizations including universities, colleges, government and tribal entities, and faith- or community-based organizations; it targets established research and technology-development teams, not individuals or general nonprofits. Award amounts are not specified. Confirm program-specific eligibility in the full announcement.
ResearchersSchools & universitiesGovernment / tribalNarrow eligibilityChange of Recipient Organization (Type 7 Parent Clinical Trial Optional)
Due Jul 12, 2027National Institutes of Health · Amount varies
This NIH mechanism is narrowly limited to organizations that already hold specific types of NIH grants and need to transfer an existing award to a new recipient institution (a change of recipient organization). It is an administrative prior-approval request, not a new funding opportunity, and there is no guarantee a transfer will be approved. Only current NIH grantee organizations should apply; it does not apply to individuals, new applicants, or general nonprofits. No award amount applies.
ResearchersSchools & universitiesGovernment / tribalNarrow eligibilityAdvancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)
Due Sep 7, 2027National Institutes of Health · Amount varies
This NIH (R21) opportunity supports exploratory community-engaged research to develop novel, culturally and linguistically responsive measures of children's language development and supportive environmental factors. Eligible applicants are research organizations including universities, colleges, government and tribal entities, and faith- or community-based organizations; it targets established research teams rather than individuals or general nonprofits. Award amounts are not specified. Confirm program-specific eligibility in the full announcement.
ResearchersSchools & universitiesGovernment / tribalNarrow eligibilityAdvancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)
Due Sep 7, 2027National Institutes of Health · Amount varies
This NIH (R01) opportunity funds community-engaged research to develop novel, culturally and linguistically responsive measures of children's language development and the environmental factors that support it. Eligible applicants are research organizations including universities, colleges, government and tribal entities, and faith- or community-based organizations; it is intended for established research teams rather than individuals or general nonprofits. Award amounts are not specified. Confirm program-specific eligibility in the full announcement.
ResearchersSchools & universitiesGovernment / tribalNarrow eligibilityNICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed)
Due Sep 25, 2027National Institutes of Health · Amount varies
This NIH (NICHD, P41) program supports continued operation, maintenance, and dissemination of bioinformatics database resources important to research using animal models of embryonic development. Eligible applicants are U.S. research organizations including universities, government and tribal entities, and faith- or community-based organizations; foreign organizations and non-U.S. components of U.S. organizations are not eligible. It is intended for institutions that operate established bioinformatics resources, not individuals or general nonprofits. Award amounts are not specified.
ResearchersSchools & universitiesGovernment / tribalNarrow eligibilityLimited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
Due Oct 19, 2027National Institutes of Health · Up to $650K
This NIH limited-competition award (UG3/UH3) funds collaborative innovation projects within the CTSA Program consortium to accelerate translational research. Eligibility is restricted per the funding notice, and foreign organizations and their U.S. components are not eligible, so this is aimed at institutions already in or aligned with the CTSA consortium rather than the general public. Awards run up to roughly $650,000. Review the notice's eligibility section closely, as access is limited.
ResearchersSchools & universitiesLarge awardNarrow eligibilityBRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)
Due Nov 8, 2027National Institutes of Health · Amount varies
This NIH BRAIN Initiative R01 funds development of computational theories, models, and methods for analyzing complex brain-circuit data, to be shared with the research community. Eligible applicants are research organizations, including faith- or community-based organizations, tribal governments, foreign organizations, and U.S. territories; it targets institutions rather than individuals. No award amount is specified. The work is narrowly scoped to neural-circuit tool building, so confirm fit before applying.
ResearchersSchools & universitiesGovernment / tribalNonprofits+1 moreLeveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)
Due Nov 15, 2027National Institutes of Health · Up to $6.3M
The purpose of this Notice of Funding Opportunity (NOFO) is to leverage NICHD clinical research Network infrastructure relevant to infants, children, women, pregnant and lactating women, and persons with disabilities to conduct innovative, multisite, investigator-initiated clinical trials and observational studies. This NOFO will utilize a bi-phasic (UG3/UH3), milestone-driven mechanism consisting of a start-up phase (UG3) and a full enrollment and clinical trial implementation phase (UH3). Applications submitted in response to this NOFO must address specific aims and milestones for both the UG3 and UH3 phases. A UG3 project (phase I) that meets its milestones will be administratively considered by NICHD and prioritized for transition to the UH3 award (phase II). This NOFO provides an opportunity to leverage NICHD clinical research Network infrastructure as a platform for investigator-initiated innovative hypotheses by any investigator in the extramural community. Applications must be submitted as investigator-initiated, multi-Project Director/Principal Investigator (PD/PI) grant applications in conjunction with the respective NICHD-supported Network Data Coordinating Center (DCC), or equivalent as determined by the NICHD.
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
Due Nov 16, 2027National Institutes of Health · Amount varies
This NIH (R01) opportunity funds research developing novel screening approaches or therapies for fatal or disabling conditions identified through newborn screening, including high-priority genetic conditions. It is intended for research and academic institutions rather than individuals or general nonprofits/small businesses. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityInnovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
Due Nov 16, 2027National Institutes of Health · Up to $200K
This NIH (R21) opportunity funds research developing novel screening approaches or therapies for fatal or disabling conditions identified through newborn screening, including high-priority genetic conditions. It is intended for research and academic institutions rather than individuals or general nonprofits/small businesses. The maximum award is about $200,000.
ResearchersSchools & universitiesNarrow eligibilityAcademic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Up to $375K
An NIH Academic Research Enhancement Award (AREA/R15) for undergraduate-focused institutions that do not receive substantial NIH funding, supporting small-scale biomedical research with undergraduate involvement. Eligibility is narrow: institutions must award baccalaureate science degrees and have received no more than about $6 million per year of NIH support in 4 of the last 7 years; foreign organizations are not eligible. The award is capped at about $375,000. This is restricted to qualifying lower-NIH-funded undergraduate institutions.
ResearchersSchools & universitiesNarrow eligibilityDissemination and Implementation Research in Health (R21 Clinical Trial Optional)
Due Jan 7, 2028National Institutes of Health · Amount varies
The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged.All applications must be within the scope of the mission of one of the Institutes/Centers listed above.
NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Up to $50K
The NIH parent Small Research Grant (R03, clinical trial not allowed) supports small, short-term projects such as pilot and feasibility studies, secondary data analysis, and methodology development. A broad range of domestic and foreign institutions may apply, including universities, tribal governments, and community-based organizations. The award is capped at about $50,000. The small budget suits research institutions pursuing limited-scope projects to generate preliminary data.
ResearchersSchools & universitiesGovernment / tribalNonprofits+2 moreDissemination and Implementation Research in Health (R01 Clinical Trial Optional)
Due Jan 7, 2028National Institutes of Health · Amount varies
The purpose of this Notice of Funding Opportunity (NOFO) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, sustainability, scale-up, and spread of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies (hereafter referred to as evidence-based interventions). Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services that may be disrupted amidst disasters (e.g., pandemics) remain relevant. All applications must be within the scope of the mission of one of the Institutes/Centers listed above.
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Amount varies
The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. All applications must be within the scope of the mission of one of the Institutes/Centers listed above.
Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)
Due Jan 7, 2028National Institutes of Health · Amount varies
The purpose of this Notice of Funding Opportunity (NOFO) encourages applications that will expand knowledge of the natural history of disorders that currently are, or may become, part of statewide newborn screening programs. A comprehensive understanding of the natural history of a condition is necessary to facilitate appropriate interventions for infants identified by newborn screening. Characterization of the sequence and timing of symptom development provides information crucial for developing targeted, age-appropriate treatments and for establishing a baseline against which to assess novel interventions. In addition, for some conditions, establishment of genotype-phenotype correlations may facilitate prediction of the clinical course; for others, identification of modifying genetic, epigenetic, or environmental factors may enhance understanding of clinical outcomes. Comprehensive data on the natural history of a condition will facilitate the fields ability to: 1) identify the underlying biological mechanisms; 2) understand the genetic and clinical heterogeneity and phenotypic expression of the condition; 3) improve diagnostic accuracy; 4) facilitate clinical trials by providing comprehensive natural history data; 5) prevent, manage, and treat symptoms and complications of the condition; 6) furnish physicians and families with needed support and predictive information about the condition; and 7) establish data collection systems or patient registries to collect longitudinal data (e.g., child/family outcomes following newborn screening).
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Up to $375K
The purpose of the Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools is to stimulate basic and clinical research in educational institutions that provide baccalaureate or advanced degrees for a significant number of the Nation's research scientists, but that have not been major recipients of NIH support. REAP grants create opportunities for scientists and institutions otherwise unlikely to participate extensively in NIH research programs to contribute to the Nation's biomedical and behavioral research effort. REAP grants are intended to support small-scale research projects proposed by faculty members of eligible, domestic institutions, to expose undergraduate and/or graduate students at health professional schools or graduate schools to meritorious research projects, and to strengthen the research environment of the applicant institution.Eligible institutions must award NIH-relevant baccalaureate or advanced degrees in health professions and have received less than $6 million per year of NIH support (total costs) in 4 of the last 7 fiscal years. In this NOFO, a college is a stand-alone entity and not a component of a university system.
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIH AREA (R15) award funds small-scale research at undergraduate-focused institutions that receive limited NIH funding, emphasizing undergraduate research experiences; a minimal-risk clinical trial is required. Eligible institutions must grant baccalaureate science degrees and have received no more than about $6 million per year of NIH support in 4 of the last 7 years; foreign organizations are not eligible. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityNICHD Small Research Grant Program (R03 Clinical Trial Required)
Due Jan 7, 2028National Institutes of Health · Up to $50K
An NIH/NICHD Small Research Grant (R03, clinical trial required) supporting small clinical-trial projects within the NICHD mission. Eligible applicants include a broad range of domestic and foreign institutions such as universities, tribal governments, and community-based organizations. The award is capped at about $50,000. The small budget and clinical-trial requirement make this best suited to research institutions running limited-scope pilot trials.
ResearchersSchools & universitiesGovernment / tribalNonprofits+2 moreScreening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Amount varies
An NIH research project grant (R01, clinical trial not allowed) supporting screening and functional validation of genomic variants linked to human congenital anomalies, developmental disabilities, and inborn errors of metabolism. A broad set of domestic and foreign institutions may apply, including universities, tribal governments, and community-based organizations. No specific award amount is stated. This is a basic-science genomics mechanism for research institutions.
ResearchersSchools & universitiesGovernment / tribalNonprofits+1 more